Dr. Rahul Gupta, Director of National Drug Control Policy at the White House, outlines the federal government's response to the threat of Xylazine; the 2024 Diverse Executives Leading in Public Health (DELPH) Program is accepting applications for professional development; a new ASTHO blog article explains how data modernization intersects with diversity, equity, and inclusion; and the Morning Edition celebrates its 500th episode.

ASTHO Webpage: Public Health Officials Stand Ready to Implement White House Xylazine Response Plan

ASTHO Webpage: Diverse Executives Leading in Public Health Application

ASTHO Webpage: The Search for Good Data to Support Health Equity in Public Health

500: Xylazine Plan, Diverse Executives Address Equity